One of the most important tools to combat the ongoing COVID-19 pandemic has been diagnosis and contact tracing. The current diagnostic toolbox consists of PCR or antibody-based tests. While the rapid antibody-based assays are useful for their speed, they still lack in sensitivity and high-quality antibodies are costly and complicated to produce. We would like to develop biomimetic sensors for a more sensitive, robust and low-cost rapid diagnostic tool for the SARS-CoV-2 virus.